SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS (SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS (SLE) trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug MTM-H-001 targets B-Cell autoimmune diseases in early trial
Disease control Not yet recruitingThis early study tests a new drug called MTM-H-001 in 75 adults with B-cell-related autoimmune diseases, including lupus, multiple sclerosis, and rheumatoid arthritis. The main goal is to check safety and find the right dose. Participants receive the drug by injection, and resear…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: NA • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Immune cells engineered to fight lupus enter first human tests
Disease control Not yet recruitingThis early-stage trial tests a new treatment called KN5501 for people with moderate to severe lupus that hasn't responded to standard therapies. The treatment uses specially engineered immune cells (CAR-NK cells) to target and destroy faulty B cells that drive the disease. Partic…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: PHASE1 • Sponsor: Ruitherapeutics Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC